Literature DB >> 12031601

Decrease of serum dipeptidylpeptidase activity in severe sepsis patients: relationship to procalcitonin.

Andreas Bergmann1, Claude Bohuon.   

Abstract

A significant decrease of DPP IV activity has been found in patients with severe sepsis in relationship to the increase of procalcitonin. These findings might be explained by the high concentration of other substrates for DPP IV present in these patients. It can be hypothesized that this enzymatic decrease is bound to some changes in immunomodulation. Further studies will be necessary to elucidate the clinical importance of these findings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031601     DOI: 10.1016/s0009-8981(02)00042-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

2.  Monitoring of the effects of transfection with baculovirus on Sf9 cell line and expression of human dipeptidyl peptidase IV.

Authors:  Ozlem Ustün-Aytekin; Ismet Deliloğlu Gürhan; Kayoko Ohura; Teruko Imai; Gaye Ongen
Journal:  Cytotechnology       Date:  2013-05-29       Impact factor: 2.058

3.  Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2).

Authors:  Gwendolyn Vliegen; Kaat Kehoe; An Bracke; Emilie De Hert; Robert Verkerk; Erik Fransen; Bart 's Jongers; Esther Peters; Anne-Marie Lambeir; Samir Kumar-Singh; Peter Pickkers; Philippe G Jorens; Ingrid De Meester
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

4.  Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients.

Authors:  Ákos Nádasdi; György Sinkovits; Ilona Bobek; Botond Lakatos; Zsolt Förhécz; Zita Z Prohászka; Marienn Réti; Miklós Arató; Gellért Cseh; Tamás Masszi; Béla Merkely; Péter Ferdinandy; István Vályi-Nagy; Zoltán Prohászka; Gábor Firneisz
Journal:  Biomark Med       Date:  2022-02-23       Impact factor: 2.851

5.  Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS.

Authors:  Longxiang Su; Lichao Cao; Ruo Zhou; Zhaoxu Jiang; Kun Xiao; Weijing Kong; Huijuan Wang; Jie Deng; Bo Wen; Fengji Tan; Yong Zhang; Lixin Xie
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.